ICN International AG
Company Overview
Previous Company Names
- Pharba Basel AG
- (Pharba Bâle SA) (Pharba Basle Ltd)
Management
Luka Valas
Basel
Member of the board
Joint signing authority (any two to sign)
Timothy Tyson
Newport Coast / California, US
Chairperson of the board
Joint signing authority (any two to sign)
Dr. Wolfgang Kissel
Oberwil BL
Member of the board
Joint signing authority (any two to sign)
Dr. Beyeler
Arlesheim
Member of the board
Individual signing authority
Milan Panic
Pasadena
Chairperson of the board
Joint signing authority (any two to sign)
Max Brauchli
Binningen
Vice-chairperson of the board
Joint signing authority (any two to sign)
Andrey Kozyrev
Moskau
Vice-chairperson of the board
Joint signing authority (any two to sign)
Ferenc Bartha
Budapest
Member of the board
Joint signing authority (any two to sign)
Adam Jerney
Newport Beach
Member of the board
Joint signing authority (any two to sign)
Jean-François Kurz
Trélex
Member of the board
Joint signing authority (any two to sign)
Thomas Lenagh
Flemington
Member of the board
Joint signing authority (any two to sign)
Robert White O'Leary
Rancho SantaFe (California, USA)
Chairperson of the board
Joint signing authority (any two to sign)
Remo Inglin
Bubendorf
Member of the board
Joint signing authority (any two to sign)
Building smart people network graph...
Fetching people and their companies
Address & Locations
Primary Address
Loading map...
| No. | Journal No. | Journal date | SOGC | SOGC date | Page / ID |
|---|---|---|---|---|---|
| 1 | 2673 | 27.06.2005 | 126 | 01.07.2005 | 7/2911700 |
| 2 | 3010 | 06.07.2004 | 132 | 12.07.2004 | 6/2353674 |
| 3 | 1873 | 30.04.2004 | 87 | 06.05.2004 | 4/2248494 |
| 4 | 2808 | 27.06.2003 | 125 | 03.07.2003 | 6 |
| 5 | 4194 | 02.10.2002 | 194 | 08.10.2002 | 5 |
| 6 | 1183 | 18.03.2002 | 57 | 22.03.2002 | 5 |
| 7 | 670 | 07.02.2002 | 30 | 13.02.2002 | 5 |
| 8 | 3210 | 03.07.2001 | 130 | 09.07.2001 | 5210 |
| 9 | 1512 | 15.03.2001 | 56 | 21.03.2001 | 2087 |
| 10 | (Transfer seat) | (Transfer seat) |
Company Purpose
Beteiligung an vornehmlich ausländischen Unternehmen, insbesondere im pharmazeutischen Bereich. Die Gesellschaft kann ihre Tätigkeit auf verwandte Branchen ausdehnen, Grundstücke erwerben, veräussern und verwalten und gleiche oder ähnliche Unternehmen erwerben oder sich daran beteiligen.